Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2026-01-09 @ 4:24 PM
Study NCT ID:
NCT00065156
Status:
COMPLETED
Last Update Posted:
2019-11-19
First Post:
2003-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
Sponsor:
Celgene
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CC-5013-MDS-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None